Literature DB >> 30720675

Emotion-Focused Avoidance Coping Mediates the Association Between Pain and Health-Related Quality of Life in Children With Sickle Cell Disease.

Crystal S Lim1, Cynthia Karlson2, Sara N Edmond3,4, Josie S Welkom5, Ifeyinwa Osunkwo6, Lindsey L Cohen7.   

Abstract

Sickle cell disease (SCD) is associated with pain and decreased health-related quality of life (HRQOL). Coping strategies influence pain but have not been evaluated as mediating the relation between pain and HRQOL in pediatric SCD. The current study examined whether pain-related coping mediates the association between pain and HRQOL in children and adolescents with SCD. In total, 104 children and adolescents 8 to 18 years of age (Mage=12.93 y) with SCD attending outpatient clinics completed pain intensity, HRQOL, and pain-related coping measures. Multiple mediation analyses were used to examine whether pain-related coping mediated the pain and HRQOL relation and whether types of coping (ie, approach, emotion-focused avoidance, problem-focused avoidance) were independent mediators. Total indirect effects for models examining physical and psychosocial HRQOL were not significant. After controlling for covariates, emotion-focused avoidance significantly mediated the association between pain and physical HRQOL (effect: -0.023; bootstrapped SE: 0.018; 95% confidence interval: -0.0751, -0.0003) but not the pain and psychosocial HRQOL relation. Approach and problem-focused avoidance were not significant mediators. Coping with pain in pediatric SCD is an important avenue for clinical intervention and additional research. Among children with SCD reporting high pain intensity, interventions should emphasize negative impacts of emotion-focused avoidance coping and integrate other empirically supported coping strategies to improve HRQOL.

Entities:  

Mesh:

Year:  2019        PMID: 30720675      PMCID: PMC6461213          DOI: 10.1097/MPH.0000000000001429

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  35 in total

1.  Cognitive Abilities Moderate the Effect of Disease Severity on Health-Related Quality of Life in Pediatric Sickle Cell Disease.

Authors:  Steven J Hardy; Sarah E Bills; Shane M Wise; Kristina K Hardy
Journal:  J Pediatr Psychol       Date:  2018-09-01

2.  A biopsychosocial-spiritual model of chronic pain in adults with sickle cell disease.

Authors:  Lou Ella V Taylor; Nancy A Stotts; Janice Humphreys; Marsha J Treadwell; Christine Miaskowski
Journal:  Pain Manag Nurs       Date:  2011-12-14       Impact factor: 1.929

3.  Examining Biopsychosocial Factors in Relation to Multiple Pain Features in Pediatric Sickle Cell Disease.

Authors:  Alyssa M Schlenz; Jeffrey Schatz; Carla W Roberts
Journal:  J Pediatr Psychol       Date:  2016-02-10

4.  Family Functioning, Medical Self-Management, and Health Outcomes Among School-Aged Children With Sickle Cell Disease: A Mediation Model.

Authors:  Alexandra M Psihogios; Lauren C Daniel; Reem Tarazi; Kim Smith-Whitley; Chavis A Patterson; Lamia P Barakat
Journal:  J Pediatr Psychol       Date:  2018-05-01

5.  Risk-resistance adaptation model for caregivers and their children with sickle cell syndromes.

Authors:  R T Brown; R Lambert; D Devine; K Baldwin; R Casey; K Doepke; C E Ievers; L Hsu; I Buchanan; J Eckman
Journal:  Ann Behav Med       Date:  2000

6.  Pain, quality of life, and coping in sickle cell disease.

Authors:  P Fuggle; P A Shand; L J Gill; S C Davies
Journal:  Arch Dis Child       Date:  1996-09       Impact factor: 3.791

7.  Validation of the pediatric cardiac quality of life inventory.

Authors:  Bradley S Marino; Ryan S Tomlinson; Gil Wernovsky; Dennis Drotar; Jane W Newburger; Lynn Mahony; Kathleen Mussatto; Elizabeth Tong; Mitchell Cohen; Charlotte Andersen; David Shera; Philip R Khoury; Jo Wray; J William Gaynor; Mark A Helfaer; Anne E Kazak; Judy A Shea
Journal:  Pediatrics       Date:  2010-08-30       Impact factor: 7.124

8.  Examination of risk and resiliency in a pediatric sickle cell disease population using the psychosocial assessment tool 2.0.

Authors:  Cynthia W Karlson; Stacey Leist-Haynes; Maria Smith; Melissa A Faith; T David Elkin; Gail Megason
Journal:  J Pediatr Psychol       Date:  2012-07-26

9.  Health-related quality of life in children with newly diagnosed cancer: a one year follow-up study.

Authors:  Markus A Landolt; Margarete Vollrath; Felix K Niggli; Hanspeter E Gnehm; Felix H Sennhauser
Journal:  Health Qual Life Outcomes       Date:  2006-09-20       Impact factor: 3.186

10.  Quality of life among adolescents with sickle cell disease: mediation of pain by internalizing symptoms and parenting stress.

Authors:  Lamia P Barakat; Chavis A Patterson; Lauren C Daniel; Carlton Dampier
Journal:  Health Qual Life Outcomes       Date:  2008-08-09       Impact factor: 3.186

View more
  4 in total

1.  The distinct longitudinal impact of pain catastrophizing on pain interference among youth living with sickle cell disease and chronic pain.

Authors:  Mallory B Schneider; Alison Manikowski; Lindsey Cohen; Carlton Dampier; Soumitri Sil
Journal:  J Behav Med       Date:  2022-02-16

2.  Autonomically-mediated decrease in microvascular blood flow due to mental stress and pain in sickle cell disease: A target for neuromodulatory interventions.

Authors:  Sarah R Martin; Payal Shah; Christopher Denton; Lonnie K Zeltzer; Saranya Veluswamy; Michael C K Khoo; Thomas D Coates
Journal:  Complement Ther Med       Date:  2020-02-15       Impact factor: 2.446

Review 3.  Effectiveness of animal-assisted therapy on pain in children: A systematic review and meta-analysis.

Authors:  Yuanyuan Zhang; Fanghong Yan; Sijun Li; Yutan Wang; Yuxia Ma
Journal:  Int J Nurs Sci       Date:  2020-12-18

4.  Prevalence of enuresis and its impact in quality of life of patients with sickle cell disease.

Authors:  Alana de Medeiros Nelli; Flavia Cristina de Carvalho Mrad; Mateus de Andrade Alvaia; Heros Aureliano Antunes da Silva Maia; Carina Oliveira Silva Guimarães; Evanilda Souza de Santana Carvalho; Cristiano Mendes Gomes; José Murillo Bastos; Jose de Bessa
Journal:  Int Braz J Urol       Date:  2019 Sep-Oct       Impact factor: 3.050

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.